Skip to main content

29th March 2022    

29th March 2022 - Harnessing the epigenetic footprint of cervical samples for breast and ovarian cancer detection and prediction

29th March 2022    

29th March 2022 - Harnessing the epigenetic footprint of cervical samples for breast and ovarian cancer detection and prediction

  • Dr Chiara Herzog gave an introduction and background a research programme aiming to detect four women’s cancers – breast, ovarian, endometrial, and cervical – using a single test, present current results and introduce the methodology of this new test, and provide an insight into ongoing and future trials looking at longitudinal risk monitoring using the WID test.